- Home
- WSFS vs KNSA Comparison
WSFS vs KNSA Comparison
Compare WSFS & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSFS | KNSA |
|---|---|---|
| Founded | 1980 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | WSFS | KNSA |
|---|---|---|
| Price | $58.09 | $41.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $64.25 | $51.33 |
| AVG Volume (30 Days) | ★ 420.5K | 367.0K |
| Earning Date | 01-26-2026 | 10-28-2025 |
| Dividend Yield | ★ 1.17% | N/A |
| EPS Growth | ★ 9.94 | N/A |
| EPS | ★ 4.83 | 0.47 |
| Revenue | ★ $1,011,052,000.00 | $597,973,000.00 |
| Revenue This Year | N/A | $62.63 |
| Revenue Next Year | $0.22 | $29.93 |
| P/E Ratio | ★ $12.00 | $88.83 |
| Revenue Growth | 4.02 | ★ 55.68 |
| 52 Week Low | $42.44 | $17.82 |
| 52 Week High | $59.67 | $42.98 |
Technical Indicators
Market Signals| Indicator | WSFS | KNSA |
|---|---|---|
| Relative Strength Index (RSI) | 64.19 | 58.78 |
| Support Level | $57.08 | $41.05 |
| Resistance Level | $58.84 | $42.32 |
| Average True Range (ATR) | 1.20 | 1.44 |
| MACD | 0.14 | -0.06 |
| Stochastic Oscillator | 76.43 | 81.16 |
Price Performance
Historical ComparisonAbout WSFS WSFS Financial Corporation
WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: WSFS Bank provides loans and leases and other financial products to commercial and consumer customers. Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and Wealth Management provides a broad array of planning and advisor services, investment management, personal and institutional trust services, and credit and deposit products to individuals, corporate, and institutional clients. Majority revenue is generated from WSFS Bank segment.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.